Dorsey Wright & Associates

Position in LLY — ELI LILLY & Co

CIK 1376772 PASADENA, CA

Position in LLY

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$561,333

+$94,090 QoQ

Shares Held

468

-7.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#3,663

of 4,605 holders

Holding Since

Sep 2021

19 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Dorsey Wright & Associates holds $9,326,220 across 5 Drug Manufacturers - General names. LLY ranks #4 (6.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	19,191	$4,873,938
2	NVS	Novartis AG	11,585	$1,815,601
3	GSK	GSK plc	32,575	$1,707,581
4	LLY	ELI LILLY & Co This page	468	$561,333
5	MRK	Merck & Co., Inc.	2,862	$367,767

19 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$561,333	468	-7.9%	Shares	Sole	2026-08-06
2026-03-31	$467,243	508	—	Shares	Sole	2026-05-06
2025-12-31	$503,000	0	-100.0%	Shares	Sole	2026-02-20
2025-09-30	$357,084	468	0.0%	Shares	Sole	2025-11-18
2025-06-30	$364,820	468	0.0%	Shares	Sole	2025-08-11
2025-03-31	$386,525	468	-97.2%	Shares	Sole	2025-05-06
2024-12-31	$12,791,268	16,569	-11.6%	Shares	Sole	2025-02-12
2024-09-30	$16,596,314	18,733	+1.5%	Shares	Sole	2024-11-15
2024-06-30	$16,715,125	18,462	+0.0%	Shares	Sole	2024-08-15
2024-03-31	$14,361,141	18,460	+16.9%	Shares	Sole	2024-05-09
2023-12-31	$9,203,140	15,788	-6.3%	Shares	Sole	2024-02-13
2023-09-30	$9,047,417	16,844	+2.6%	Shares	Sole	2023-11-07
2023-06-30	$7,697,368	16,413	-2.5%	Shares	Sole	2023-07-26
2023-03-31	$5,779,758	16,830	-24.7%	Shares	Sole	2023-04-20
2022-12-31	$8,179,450	22,358	+189.8%	Shares	Sole	2023-02-14
2022-06-30	$2,501,110	7,714	+392.0%	Shares	Sole	2022-07-20
2022-03-31	$449,028	1,568	-82.6%	Shares	Sole	2022-04-27
2021-12-31	$2,482,112	8,986	-3.4%	Shares	Sole	2022-01-27
2021-09-30	$2,148,533	9,299	—	Shares	Sole	2021-10-26
No filing history on record for this holder in this stock.